Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2014-09-12
DOI
10.1155/2014/154702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation
- (2017) Y.B. Shaik-Dasthagirisaheb et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance
- (2014) Ilaria Marech et al. BMC CANCER
- Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF- 1
- (2014) L. Woodman et al. JOURNAL OF IMMUNOLOGY
- Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer
- (2013) Takeshi Gocho et al. CANCER LETTERS
- Mast Cell Tryptase Induces Microglia Activation via Protease-activated Receptor 2 Signaling
- (2013) Shu Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
- (2013) G. Ranieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tyrosine kinase inhibitors (TKIs) in human and pet tumours with special reference to breast cancer: A comparative review
- (2013) Girolamo Ranieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: A new treatment for metastatic soft tissue sarcoma
- (2013) Girolamo Ranieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Masitinib (AB1010), from canine tumor model to human clinical development: Where we are?
- (2013) Ilaria Marech et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
- (2013) Mitchell Cheung et al. CURRENT CANCER DRUG TARGETS
- Activation of Protease-Activated Receptor 2-Mediated Signaling by Mast Cell Tryptase Modulates Cytokine Production in Primary Cultured Astrocytes
- (2013) Xiaoning Zeng et al. MEDIATORS OF INFLAMMATION
- Mast Cell Positivity to Tryptase Correlates with Metastatic Lymph Nodes in Gastrointestinal Cancer Patients Treated Surgically
- (2013) Michele Ammendola et al. ONCOLOGY
- Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
- (2012) G. Ranieri et al. CURRENT MEDICINAL CHEMISTRY
- Therapeutic targeting of c-KIT in cancer
- (2012) Leonie K Ashman et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations
- (2012) Giovanni Brandi et al. PLoS One
- Phase II Study of Gemcitabine in Combination With Regional Arterial Infusion of Nafamostat Mesilate for Advanced Pancreatic Cancer
- (2011) Tadashi Uwagawa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation
- (2011) Anita Mangia et al. HISTOPATHOLOGY
- Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay
- (2011) Domenico Ribatti et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition
- (2011) Yuki Fujiwara et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer
- (2010) Venkateswaran Subramaniam et al. ANTI-CANCER DRUGS
- Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors
- (2010) C. Damiano Gadaleta et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells
- (2010) Venkateswaran Subramaniam et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Mast cells and angiogenesis in gastric carcinoma
- (2010) Domenico Ribatti et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Tranilast inhibits the growth and metastasis of mammary carcinoma
- (2009) Rabindranath Chakrabarti et al. ANTI-CANCER DRUGS
- Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation
- (2009) Steven Maltby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The mast cell: an evolutionary perspective
- (2009) Enrico Crivellato et al. BIOLOGICAL REVIEWS
- Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer
- (2009) Sanjeev Banerjee et al. CANCER RESEARCH
- The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
- (2009) Shu Zhang et al. ENDOCRINE-RELATED CANCER
- Our perception of the mast cell from Paul Ehrlich to now
- (2009) Michael A. Beaven EUROPEAN JOURNAL OF IMMUNOLOGY
- Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients
- (2009) Ranieri INTERNATIONAL JOURNAL OF ONCOLOGY
- Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation
- (2009) Julie M. Hall et al. MOLECULAR ENDOCRINOLOGY
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes
- (2009) Kouji Izumi et al. PROSTATE
- Physiological and pathophysiological functions of intestinal mast cells
- (2009) Stephan C. Bischoff Seminars in Immunopathology
- A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
- (2008) T. Uwagawa et al. ANNALS OF ONCOLOGY
- Fitting a xenobiotic receptor into cell homeostasis: How the dioxin receptor interacts with TGFβ signaling
- (2008) Aurea Gomez-Duran et al. BIOCHEMICAL PHARMACOLOGY
- AHR-mediated immunomodulation: The role of altered gene transcription
- (2008) Nancy I. Kerkvliet BIOCHEMICAL PHARMACOLOGY
- SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
- (2008) B. Huang et al. BLOOD
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor- B Transcription and Evasion of Apoptosis
- (2008) C. Wilson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasis
- (2007) Stephen J. Galli et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer
- (2007) Maya Gulubova et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now